Operating activities: | |
Net income | 246.2M |
Adjustments to reconcile net income to net cash used in operating activities: | |
Depreciation and amortization expense | 166.7M |
Deferred income tax benefit | 500K |
(Gain) loss on sales of property, plant and equipment | -1.1M |
Equity in earnings of unconsolidated entities | |
Dividends received from unconsolidated entity | |
Share based compensation expense | 17.8M |
Tax deficit (excess benefit) from share based compensation | |
Net loss from life insurance policies | |
Changes in operating assets and liabilities: | |
Accounts receivable | -112M |
Inventories | -95.5M |
Prepaid expenses and other assets | 35.2M |
Accounts payable and other liabilities | 72.2M |
Net cash used in operating activities | |
Investing activities: | |
Purchases of property, plant and equipment | -110.6M |
Proceeds from sales of property, plant and equipment | |
Net proceeds from redemption of life insurance policies | |
Net cash used in investing activities | |
Financing activities: | |
Net short-term debt borrowings | -11.9M |
Proceeds from long-term debt borrowings | 1.71B |
Principal payments on long-term debt | -1.53B |
Payments to noncontrolling interest holders | |
Dividends paid | |
(Tax deficit) excess benefit from share based compensation | |
Exercise of stock options | 31.3M |
Net cash provided by financing activities | |
Effect of exchange rate changes on cash | |
Increase in cash and cash equivalents | 39M |
Cash and cash equivalents at beginning of year | 104.3M |
Cash and cash equivalents at end of period | 143.3M |
Supplemental cash flow information: | |
Interest paid during the period | |
Income taxes paid during the period |